ConductScience.org, home

Paper3940480

A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial.

Hoofnagle JH and 8 others. Ann Intern Med, 1986. Cited by 127 papers, by iCite.

Cite this record

ConductScience Library. A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial. Papers, record 3940480. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3940480

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial.
PubMed
Journal
Ann Intern Med
PubMed
Year
1986
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
127
iCite
Relative citation ratio, by iCite
4.94
iCite
Revised in PubMed
2019-06-19
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hoofnagle JHJ H
2Davis GLG L
3Pappas SCS C
4Hanson RGR G
5Peters MM
6Avigan MIM I
7Waggoner JGJ G
8Jones EAE A
9Seeff LBL B

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis BMajor topic
Hepatitis, ChronicMajor topic
PrednisoloneMajor topic
Adult
Alanine Transaminase
DNA-Directed DNA Polymerase
Double-Blind Method
Drug Administration Schedule
Drug Evaluation
Female
Humans
Leukocyte Count
Liver
Male
Middle Aged
Random Allocation

Source PubMed

Download CSV of topics

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 127 citations.

PMIDTitleJournalYearIn PapersSource
32206094Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations.Ther Adv Musculoskelet Dis2020https://conductscience.org/library/papers/32206094PubMed
29637482Antiviral prophylaxis for preventing reactivation of hepatitis B virus in rheumatic patients: a systematic review and meta-analysis.Clin Rheumatol2018https://conductscience.org/library/papers/29637482PubMed
28509215De novo acute hepatitis B in myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody-related microscopic polyangiitis treated with corticosteroids.CEN Case Rep2013https://conductscience.org/library/papers/28509215PubMed
28243035Infections in severe alcoholic hepatitis.Ann Gastroenterol2017https://conductscience.org/library/papers/28243035PubMed
27291888Prevention of Hepatitis B reactivation in the setting of immunosuppression.Clin Mol Hepatol2016https://conductscience.org/library/papers/27291888PubMed
25954478Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure.World J Hepatol2015https://conductscience.org/library/papers/25954478PubMed
25412906Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg?Hepatology2015https://conductscience.org/library/papers/25412906PubMed
24247262Management of patients with hepatitis B who require immunosuppressive therapy.Nat Rev Gastroenterol Hepatol2014https://conductscience.org/library/papers/24247262PubMed
22715258Adrenalectomy to treat reactivated chronic hepatitis B infection in a patient with a steroid-secreting adrenal tumour.BMJ Case Rep2011https://conductscience.org/library/papers/22715258PubMed
20614156The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B.J Gastroenterol2010https://conductscience.org/library/papers/20614156PubMed
19340912A combination treatment of entecavir and early-phase corticosteroid in severe exacerbation of chronic hepatitis B.World J Gastroenterol2009https://conductscience.org/library/papers/19340912PubMed
18807133Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B.J Gastroenterol2008https://conductscience.org/library/papers/18807133PubMed
16927141Reactivation of hepatitis B virus in rheumatologic patients receiving immunosuppressive agents.Dig Dis Sci2006https://conductscience.org/library/papers/16927141PubMed
15754390Importance of adequate immunosuppressive therapy for the recovery of patients with "life-threatening" severe exacerbation of chronic hepatitis B.World J Gastroenterol2005https://conductscience.org/library/papers/15754390PubMed
15106184Glucocorticosteroids for viral hepatitis C.Cochrane Database Syst Rev2004https://conductscience.org/library/papers/15106184PubMed
14566463[Virus associated glomerulonephritis].Internist (Berl)2003https://conductscience.org/library/papers/14566463PubMed
11855559
Long-term clinical remission induced by corticosteroid withdrawal therapy (CSWT) in patients with chronic hepatitis B infection: a prospective randomized controlled trial--CSWT with and without follow-up interferon-alpha therapy.
Dig Dis Sci2002https://conductscience.org/library/papers/11855559PubMed
9790464Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy.Dig Dis Sci1998https://conductscience.org/library/papers/9790464PubMed
7711410Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infection.Clin Investig1994https://conductscience.org/library/papers/7711410PubMed
2655856Measuring quality of life in clinical trials: a taxonomy and review.CMAJ1989https://conductscience.org/library/papers/2655856PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3940480

GET https://conductscience.org/api/papers/v1/3940480/cited_by?page=2